EXECUTIVE CHANGE SUMMARY: Prospex Energy appoints Tom Reynolds as CEO
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News: Read More
| Price | 11.00p on 14-01-2026 at 19:25:05 |
|---|---|
| Change | 0.20p 1.68% |
| Buy | 12.00p |
| Sell | 10.00p |
| Last Trade: | Buy 10,000.00 at 12.10p |
| Day's Volume: | 510,180 |
| Last Close: | 12.10p |
| Open: | 12.10p |
| ISIN: | GB00B02LCQ05 |
| Day's Range | 10.75p - 12.10p |
| 52wk Range: | 5.25p - 12.10p |
| Market Capitalisation: | £743.11m |
| VWAP: | 11.19132p |
| Shares in Issue: | 6.14b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Allergy Thera. (AGY) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 10,000 | 12.10p | Suspected BUY Trade |
16:35:01 - 14-Jan-26 |
| Buy* | 100 | 12.00p | SI Trade |
15:47:16 - 14-Jan-26 |
| Buy* | 3,333 | 12.00p | SI Trade |
15:47:16 - 14-Jan-26 |
| Buy* | 21 | 12.00p | SI Trade |
15:47:16 - 14-Jan-26 |
| Buy* | 60 | 12.00p | SI Trade |
15:47:16 - 14-Jan-26 |
| Buy* | 83 | 12.00p | SI Trade |
15:47:16 - 14-Jan-26 |
| Buy* | 7,142 | 10.90p | Suspected BUY Trade |
14:42:08 - 14-Jan-26 |
| Buy* | 56,659 | 10.8666p | Ordinary |
14:27:30 - 14-Jan-26 |
| Buy* | 14,000 | 11.20p | Suspected BUY Trade |
14:00:21 - 14-Jan-26 |
| Unknown* | 150,000 | 11.0888p | Ordinary |
12:29:46 - 14-Jan-26 |
Allergy Thera. (AGY) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th Jan 2026 7:00 am | RNS | Notice of 2025 Annual General Meeting |
| 29th Dec 2025 1:07 pm | RNS | Results of General Meeting |
| 29th Dec 2025 1:07 pm | RNS | Results of General Meeting |
| 16th Dec 2025 7:00 am | RNS | Grassmuno® marketing authorisation in Germany |
| 12th Dec 2025 7:00 am | RNS | Authority for allotment of New Shares |
| 11th Dec 2025 7:00 am | RNS | Prelim Results and publication of Annual Report |
| 9th Dec 2025 7:00 am | RNS | Primary Safety Endpoint Met in PROTECT trial |
| 6th Nov 2025 7:22 am | RNS | Company to Evaluate Dual Listing on HKEX |
| 30th Oct 2025 7:00 am | RNS | G308 Phase III Year 2 Patient Screening Starts |
| 29th Oct 2025 7:00 am | RNS | Warrant Exercise and Paydown of Debt |